US Stock MarketDetailed Quotes

VVOS Vivos Therapeutics

Watchlist
  • 2.3486
  • -0.0814-3.35%
Trading May 8 14:00 ET
7.00MMarket Cap-210P/E (TTM)

Vivos Therapeutics Key Stats

Vivos Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 28, 2024

Revenue(YoY)

3.25M

-17.77%
EPS(YoY)

-3.05

+39.00%

Buy

Apr 30, 2024

Vivos Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 3.800M--
--2024/Q1-- / 3.500M--
Mar 28, 20242023/Q43.248M / 3.406M--
Nov 14, 20232023/Q33.301M / 4.500M--
Aug 16, 20232023/Q23.395M / 4.117M--
Jun 8, 20232023/Q13.857M / 4.006M--
Mar 30, 20232022/Q43.950M / 4.554M--
Dec 20, 20222022/Q34.246M / ----
May 16, 20222022/Q13.460M / 4.442M--
Mar 31, 20222021/Q44.394M / 4.854M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 3.800M--
--2024/Q1-- / 3.500M--
Mar 28, 20242023/Q43.248M / 3.406M--
Nov 14, 20232023/Q33.301M / 4.500M--
Aug 16, 20232023/Q23.395M / 4.117M--
Jun 8, 20232023/Q13.857M / 4.006M--
Mar 30, 20232022/Q43.950M / 4.554M--
Dec 20, 20222022/Q34.246M / ----
May 16, 20222022/Q13.460M / 4.442M--
Mar 31, 20222021/Q44.394M / 4.854M--

Unlock Free Earnings Estimates

Vivos Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg